Biotech Stocks Facing FDA Decision In December 2019

Drugs Awaiting FDA Approval
Drugs Awaiting FDA Approval

As we begin the final month of the year, it’s time to take a look at the drug candidates lined up at the FDA altar awaiting the federal agency's decision.

So far this year, only 41 novel drugs have been approved compared to 55 during the same period last year (i.e., January to November) Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.

For the full year 2018, 59 novel drugs secured the FDA stamp of approval, representing an all-time high.

Now, let's take a look at the companies that await a ruling from the FDA in December 2019.